brand name

(redirected from brand-name)
Also found in: Dictionary, Medical, Legal, Financial.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for brand name

References in periodicals archive ?
As part of its brand-name promotion plan, the company has launched a series of advertising campaigns including using container trucks in 100 cities in mainland China to carry the company's brand name advertisements.
From 2000 to 2008, 416 brand-name drug products--different drug strengths and dosage forms of the same drug brands--had extraordinary price increases.
A generic drug must contain the same active ingredients and must be equivalent in strength and dosage to the original brand-name product.
So since generic drugs use the same active ingredients and work the same way in the body as brand-name drugs, they have the same benefits and risks as their brand-name counterparts.
The basic requirements for approval of generic and brand-name drugs are the same.
He adds that the regulations allow brand-name drug companies to stop Health Canada approval of generic drugs simply by alleging patent infringement.
Claritin is a popular option among the insurer's members and WellPoint and other companies that have raised copayments on other brand-name allergy drugs.
Facilitating Caro Cuore's successful expansion is strong brand-name recognition--and cash flow--within its home market, where it has 23 outlets, 10 of which opened last year.
Overall, companies reported committing a substantial amount of resources to brand-name selection, using a marketing orientation and involving top management extensively.
This strategy allows brand-name firms to increase profits at the expense of generic firm competition and may deter potential generic manufacturers from entering and effectively competing in the generic drug market.
Many times generic drugs have a lower copayment or coinsurance cost than brand-name drugs.
Double the number of contracts with brand-name companies within the next four years.
One of the four was the company's brand-name version, Synthroid, which is the third most widely prescribed drug in the United States.
Two key issues that Fitch closely monitored during 2006 were the effects of the initiation of Medicare Part D under the Medicare Prescription Drug Improvement and Modernization Act of 2003 and the start of a new wave of brand-name pharmaceutical patent expirations in the U.